Sugarman, Jeremy

The Limitations of “Vulnerability” as a Protection for Human Research Participants

Levine, C., Faden, R., Grady, C., Hammerschmidt, D., Eckenwiler, L., & Sugarman, J. (2004) · The American Journal of Bioethics

Ethics in Clinical ResearchEthics and bioethics in healthcare

Cited by 438

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Deeks, S. G., Archin, N., Cannon, P., Collins, S., Jones, R. B., de Jong, M. A. W. P., Lambotte, O., Lamplough, R., Ndung’u, T., Sugarman, J., et al. (2021) · Nature Medicine

HIV Research and TreatmentVirus-based gene therapy research

Cited by 377

Exploring the ethical and regulatory issues in pragmatic clinical trials

Califf, R. M., & Sugarman, J. (2015) · Clinical Trials

Ethics in Clinical ResearchBiomedical Ethics and Regulation

Cited by 191

Realizing HOPE: The ethics of organ transplantation from HIV-positive donors

Durand, C. M., Segev, D., & Sugarman, J. (2016) · Annals of Internal Medicine

Organ Donation and TransplantationEthics and bioethics in healthcare

Cited by 63

The Inescapable Relevance of Bioethics for the Practicing Clinician

Carrese, J. A., & Sugarman, J. (2006) · Chest

Ethics and bioethics in healthcareEthics in medical practice

Cited by 59

Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials

Federico, C. A., Heagerty, P. J., Lantos, J., O'Rourke, P., Rahimzadeh, V., Sugarman, J., Weinfurt, K., Wendler, D., Wilfond, B. S., & Magnus, D. (2022) · Contemporary Clinical Trials

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 11